? Core B: Vector Core Recombinant adeno-associated virus (rAAV) is a popular gene transfer platform technology to deliver transgenes for in vivo gene therapy. Our recent discovery of a diverse family of novel primate AAVs that are capable of transducing a variety of target tissues much more robustly than the first generation of AAV2-based vectors remarkably expanded the utility of rAAVs in different gene therapy applications including treatment of alpha-1 antitrypsin deficiency (AATD). The Viral Vector Core (Core B) is the central component of our collaborative effort to develop new approaches to gene therapy for AATD. The main objectives of Core B are to provide the investigators of other subprojects and Cores with high quality of preclinical grade rAAV vectors to address their specific scientific questions in a variety of animal models as well as reliable and reproducible AAV neutralizing antibody testing service. Core B will rely on the resources and experience of the University of Massachusetts Viral Vector Core (Guangping Gao, Director), an internationally well recognized vector service with abundant experience in vector production, quality control, and uses in different in vivo gene transfer applications to accomplish its goal through the following Aims:
Aim 1. To design, create, produce, purify and quality control test preclinical grade rAAV vector preparations for all subprojects and cores of this tPPG, and Aim 2. To perform in vitro and in vivo neutralizing antibody assays to screen nonhuman primate animals for studies proposed by subproject 2 and study seroepidemiology of novel AAV capsids developed by subproject 4 in human populations.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Program Projects (P01)
Project #
1P01HL131471-01
Application #
9071189
Study Section
Special Emphasis Panel (ZHL1)
Project Start
Project End
Budget Start
2016-08-01
Budget End
2017-04-30
Support Year
1
Fiscal Year
2016
Total Cost
Indirect Cost
Name
University of Massachusetts Medical School Worcester
Department
Type
DUNS #
603847393
City
Worcester
State
MA
Country
United States
Zip Code
Ibraheim, Raed; Song, Chun-Qing; Mir, Aamir et al. (2018) All-in-one adeno-associated virus delivery and genome editing by Neisseria meningitidis Cas9 in vivo. Genome Biol 19:137
Wang, Dan; Li, Jia; Song, Chun-Qing et al. (2018) Cas9-mediated allelic exchange repairs compound heterozygous recessive mutations in mice. Nat Biotechnol 36:839-842
Smith, Jordan L; Mou, Haiwei; Xue, Wen (2018) Understanding and repurposing CRISPR-mediated alternative splicing. Genome Biol 19:184
Yoon, Yeonsoo; Wang, Dan; Tai, Phillip W L et al. (2018) Streamlined ex vivo and in vivo genome editing in mouse embryos using recombinant adeno-associated viruses. Nat Commun 9:412
Song, Chun-Qing; Xue, Wen (2018) CRISPR-Cas-related technologies in basic and translational liver research. Nat Rev Gastroenterol Hepatol 15:251-252
Zhang, Wei; Li, Linjing; Su, Qin et al. (2018) Gene Therapy Using a miniCEP290 Fragment Delays Photoreceptor Degeneration in a Mouse Model of Leber Congenital Amaurosis. Hum Gene Ther 29:42-50
Tai, Phillip W L; Xie, Jun; Fong, Kaiyuen et al. (2018) Adeno-associated Virus Genome Population Sequencing Achieves Full Vector Genome Resolution and Reveals Human-Vector Chimeras. Mol Ther Methods Clin Dev 9:130-141
Borel, Florie; Sun, Huaming; Zieger, Marina et al. (2018) Editing out five Serpina1 paralogs to create a mouse model of genetic emphysema. Proc Natl Acad Sci U S A 115:2788-2793
Zhang, Xiao-Ou; Fu, Yu; Mou, Haiwei et al. (2018) The temporal landscape of recursive splicing during Pol II transcription elongation in human cells. PLoS Genet 14:e1007579
Wang, Dan; Gao, Guangping (2018) Taking a Hint from Structural Biology: To Better Understand AAV Transport across the BBB. Mol Ther 26:336-338

Showing the most recent 10 out of 42 publications